Clinical Trials Directory

Trials / Unknown

UnknownNCT05255432

Summative Evaluation to Validate the LEAFix Device With Users

Summative Evaluation to Validate That the Laryngeal, Endo-tracheal, Airway Fixator (LEAFix) Can be Used Safely and Effectively by Intended Users to Secure Airway Devices

Status
Unknown
Phase
Study type
Observational
Enrollment
32 (estimated)
Sponsor
Liverpool University Hospitals NHS Foundation Trust · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The Laryngeal Endo-tracheal Airway Fixator(LEAFix) is a single use product designed to secure airway devices to patients during anaesthesia, with better infection control management and interaction with the patients skin. This study investigates the users of the LEAFix device interacting with the LEAFix device, its packaging and a simulated patient through different scenarios of securing an airway device. The aim is to understand the risks associated with the use of the device for CE marking purposes. This study is funded by Innovel Ltd. the manufacturer of the device.

Conditions

Interventions

TypeNameDescription
OTHERnil interventionUsers observation using medical device on manakin, different scenarios per group

Timeline

Start date
2022-06-01
Primary completion
2022-08-01
Completion
2022-09-01
First posted
2022-02-24
Last updated
2022-05-11

Source: ClinicalTrials.gov record NCT05255432. Inclusion in this directory is not an endorsement.

Summative Evaluation to Validate the LEAFix Device With Users (NCT05255432) · Clinical Trials Directory